
NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Navigating A Food Desert
Many of us probably cannot imagine not having the means to eat what we want when we want. Every day we decide between something healthy…
Hypertriglyceridemia and the Risk of Cardiovascular Disease and Pancreatitis in a Veteran Population
The Veterans Health Administration (VA) is the nation’s largest integrated health care delivery system serving more than 11 million patients. There recently has been renewed…
Cardiovascular Disease in the Rural American Population
Despite significant improvements in cardiovascular disease (CVD) outcomes and decline in overall CVD deaths, CVD continues to be the leading cause of death in the…
Differences in Statin Metabolism in East Asians
Elevated plasma levels of low-density lipoprotein cholesterol (LDL-C) play a significant role in the development of Coronary Artery Disease (CAD).(1) In clinical trials, reducing LDL-C…
Management of Hypertriglyceridemia in a Patient Considered an Undocumented Immigrant
IntroductionThe management of elevated triglycerides is a means by which the burden of Atherosclerotic Cardiovascular Disease(ASCVD) may be reduced and the complication of pancreatitis may…
Tools for Alleviating Drug Disparities in Lipidology
The armamentarium for lipid-lowering pharmacotherapy is evolving. Though statins remain the cornerstone of treatment, and nearly all statins and ezetimibe are generic, recent and emerging…
Understanding Differences in ASCVD Risk and Outcomes in South Asians
A greater prevalence of dyslipidemia, insulin resistance, and atherosclerotic cardiovascular disease (ASCVD) and related-mortality are now well-recognized in South Asians living in the U.S. (SAUS),…
Risk Assessment Tools and Dietary Questionnaires
Risk assessment tools and lifestyle surveys can play a major role in screening patients for risk of atherosclerotic cardiovascular disease (ASCVD), allowing for early targeted…